$SCPX
Scorpius Holdings, Inc.

2023 Q1 Form 10-K Financial Statement

#000155837023005289 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $765.9K $79.92K $6.383M
YoY Change 260.56% -86.96% 202.12%
Cost Of Revenue $611.7K $38.24K $6.401M
YoY Change
Gross Profit $154.2K $41.68K -$17.85K
YoY Change
Gross Profit Margin 20.13% 52.15% -0.28%
Selling, General & Admin $6.821M $7.350M $20.53M
YoY Change 80.6% 26.34% 22.0%
% of Gross Profit 4424.33% 17633.23%
Research & Development $6.996M $7.940M $23.46M
YoY Change 77.86% 16.47% 24.65%
% of Gross Profit 4538.04% 19050.07%
Depreciation & Amortization $1.426M $1.490M $2.115M
YoY Change 588.49% 674.45% 248.05%
% of Gross Profit 924.95% 3574.98%
Operating Expenses $6.996M $15.54M $23.46M
YoY Change -9.01% 22.79% -37.49%
Operating Profit -$13.04M -$15.50M -$45.69M
YoY Change 74.35% 28.99%
Interest Expense $140.4K $325.8K -$703.2K
YoY Change -119.82% 21.57% -183.9%
% of Operating Profit
Other Income/Expense, Net $140.4K -$210.3K -$1.462M
YoY Change -119.68% -59.95% 1044.8%
Pretax Income -$12.90M -$15.39M -$47.15M
YoY Change 57.45% 11.86% 32.65%
Income Tax $0.00 -$3.073M -$3.289M
% Of Pretax Income
Net Earnings -$12.78M -$12.15M -$43.43M
YoY Change 57.44% -10.41% 23.85%
Net Earnings / Revenue -1669.23% -15204.55% -680.46%
Basic Earnings Per Share -$0.49 -$1.70
Diluted Earnings Per Share -$0.49 -$0.47 -$1.70
COMMON SHARES
Basic Shares Outstanding 26.05M 25.66M 25.61M
Diluted Shares Outstanding 25.97M 25.61M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.64M $44.27M $44.27M
YoY Change -65.95% -54.06% -54.06%
Cash & Equivalents $7.827M $8.435M $8.435M
Short-Term Investments $20.82M $35.84M $35.84M
Other Short-Term Assets $3.493M $3.576M $3.576M
YoY Change 47.68% 23.87% 23.87%
Inventory
Prepaid Expenses
Receivables $98.04K $81.46K $81.46K
Other Receivables $2.125M $2.125M $2.125M
Total Short-Term Assets $34.36M $50.05M $50.05M
YoY Change -60.32% -49.61% -49.61%
LONG-TERM ASSETS
Property, Plant & Equipment $19.43M $20.48M $41.81M
YoY Change 527.07% 848.83% 847.73%
Goodwill $3.302M $3.302M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.837M $556.7K $556.7K
YoY Change -76.26% -97.14% -95.51%
Total Long-Term Assets $57.16M $54.34M $54.34M
YoY Change 106.44% 151.24% 151.24%
TOTAL ASSETS
Total Short-Term Assets $34.36M $50.05M $50.05M
Total Long-Term Assets $57.16M $54.34M $54.34M
Total Assets $91.52M $104.4M $104.4M
YoY Change -19.91% -13.69% -13.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.051M $4.424M $4.424M
YoY Change 36.92% 379.43% 379.43%
Accrued Expenses $5.723M $4.302M $3.700M
YoY Change 248.08% 77.79% 33.56%
Deferred Revenue $2.039M $1.586M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $225.0K $301.1K $301.1K
YoY Change -7.86% 15.54% 15.54%
Total Short-Term Liabilities $17.48M $18.04M $18.04M
YoY Change 228.9% 282.09% 282.09%
LONG-TERM LIABILITIES
Long-Term Debt $5.470M $5.520M $5.520M
YoY Change 2424.92% 2061.07% 2061.07%
Other Long-Term Liabilities $8.229M $8.403M $8.403M
YoY Change 14840.65% 15597.53% 124.94%
Total Long-Term Liabilities $13.70M $13.92M $13.92M
YoY Change 24772.1% 25909.56% 248.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.48M $18.04M $18.04M
Total Long-Term Liabilities $13.70M $13.92M $13.92M
Total Liabilities $31.18M $31.96M $30.47M
YoY Change 225.86% 257.99% 288.06%
SHAREHOLDERS EQUITY
Retained Earnings -$221.9M -$209.2M
YoY Change 27.68% 26.24%
Common Stock $5.210K $5.126K
YoY Change 1.76% 1.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.94M $73.92M $73.92M
YoY Change
Total Liabilities & Shareholders Equity $91.52M $104.4M $104.4M
YoY Change -19.91% -13.69% -13.69%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$12.78M -$12.15M -$43.43M
YoY Change 57.44% -10.41% 23.85%
Depreciation, Depletion And Amortization $1.426M $1.490M $2.115M
YoY Change 588.49% 674.45% 248.05%
Cash From Operating Activities -$13.79M -$7.842M -$5.700M
YoY Change 35.05% -31.15% -85.05%
INVESTING ACTIVITIES
Capital Expenditures $1.625M $846.9K $20.12M
YoY Change 48.97% -262.52% 956.22%
Acquisitions -$2.720M
YoY Change
Other Investing Activities $15.11M $8.216M $31.11M
YoY Change -15.53% -32.34% 166.46%
Cash From Investing Activities $13.49M $7.369M $10.99M
YoY Change -19.72% -36.59% 12.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $59.69K
YoY Change -99.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -298.5K -4.761M -4.907M
YoY Change 440.89% 7640.64% -119.25%
NET CHANGE
Cash From Operating Activities -13.79M -7.842M -5.700M
Cash From Investing Activities 13.49M 7.369M 10.99M
Cash From Financing Activities -298.5K -4.761M -4.907M
Net Change In Cash -607.8K -5.234M 380.7K
YoY Change -109.31% -3172.65% -113.23%
FREE CASH FLOW
Cash From Operating Activities -$13.79M -$7.842M -$5.700M
Capital Expenditures $1.625M $846.9K $20.12M
Free Cash Flow -$15.42M -$8.689M -$25.82M
YoY Change 36.39% -20.05% -35.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25606326
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24913942
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001476963
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-1.31
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.40
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25649824
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25661488
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.70
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.41
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25649824
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25661488
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.10
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-35994
CY2022 dei Entity Registrant Name
EntityRegistrantName
NightHawk Biosciences, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2844103
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
627 Davis Drive, Suite 300
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Morrisville
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27560
CY2022 dei City Area Code
CityAreaCode
919
CY2022 dei Local Phone Number
LocalPhoneNumber
240-7133
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.0002 par value per share
CY2022 dei Trading Symbol
TradingSymbol
NHWK
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
65407051
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26049209
CY2022 dei Auditor Name
AuditorName
BDO USA, LLP
CY2022 dei Auditor Location
AuditorLocation
Raleigh, NC
CY2022 dei Auditor Firm
AuditorFirmId
243
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8434554
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8053879
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
35837309
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
88324922
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81456
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66049
CY2022Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
1524522
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
600877
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3575541
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2886520
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50054259
CY2021Q4 us-gaap Assets Current
AssetsCurrent
99331370
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20480375
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2158479
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8669375
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3500000
CY2022Q4 us-gaap Goodwill
Goodwill
3301959
CY2021Q4 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1318359
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6005147
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1782884
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
15329075
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
470700
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
260011
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
12193540
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
296711
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
205901
CY2022Q4 us-gaap Assets
Assets
104396912
CY2021Q4 us-gaap Assets
Assets
120961233
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4424053
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
922782
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1585808
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
490378
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
350343
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
301048
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
260574
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4301922
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2419676
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
6934114
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
593037
CY2021Q4 nhwk Business Combination Contingent Consideration Liability Related Party Current
BusinessCombinationContingentConsiderationLiabilityRelatedPartyCurrent
174333
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18037323
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4720745
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53530
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11020
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
215937
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
32500
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
35000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3079887
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1060856
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5520034
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
255429
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5290500
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1990118
CY2021Q4 nhwk Business Combination Contingent Consideration Liability Related Party Noncurrent
BusinessCombinationContingentConsiderationLiabilityRelatedPartyNoncurrent
585027
CY2022Q4 us-gaap Liabilities
Liabilities
31960244
CY2021Q4 us-gaap Liabilities
Liabilities
8927662
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-842538
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25661488
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25649824
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5126
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5055
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
283019456
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278890153
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-209153659
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165718953
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
51924
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-67941
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73922847
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
113108314
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-1486179
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-1074743
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
72436668
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112033571
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104396912
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120961233
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6383169
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2112806
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6401018
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23461400
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16455278
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21130879
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16828229
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1452338
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1030625
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3500000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2366000
CY2022 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3452015
CY2021 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
430000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
52071907
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
37531845
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-45688738
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-35419039
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11020
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-22758
CY2022 us-gaap Interest Income Other
InterestIncomeOther
987247
CY2021 us-gaap Interest Income Other
InterestIncomeOther
815316
CY2022 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-1701428
CY2021 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-842538
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-759235
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123278
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1462396
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-127742
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47151134
CY2022 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3288937
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4085737
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
6168981
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35546781
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3288937
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-145974
CY2022 us-gaap Profit Loss
ProfitLoss
-43862197
CY2021 us-gaap Profit Loss
ProfitLoss
-35400807
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-427491
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-329339
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-43434706
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-35071468
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.70
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25606326
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24913942
CY2022 us-gaap Profit Loss
ProfitLoss
-43862197
CY2021 us-gaap Profit Loss
ProfitLoss
-35400807
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119865
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
98115
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-43742332
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-35302692
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-427491
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-329339
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43314841
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34973353
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
115493923
CY2021 nhwk Stock Issued During Period Value New Issues2
StockIssuedDuringPeriodValueNewIssues2
26304282
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
658184
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
6168981
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27261
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
98115
CY2021 us-gaap Profit Loss
ProfitLoss
-35400807
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112033571
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
43637
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
4085737
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16055
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
119865
CY2022 us-gaap Profit Loss
ProfitLoss
-43862197
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
72436668
CY2022 us-gaap Profit Loss
ProfitLoss
-43862197
CY2021 us-gaap Profit Loss
ProfitLoss
-35400807
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1452338
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3500000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2366000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2115015
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
607667
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1030625
CY2022 nhwk Noncash Lease Expense
NoncashLeaseExpense
116583
CY2021 nhwk Noncash Lease Expense
NoncashLeaseExpense
83809
CY2021 nhwk Noncash Interest Expense
NoncashInterestExpense
21970
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11020
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-22758
CY2022 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3452015
CY2021 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
430000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1701443
CY2021 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-145974
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15967
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-110111
CY2022 nhwk Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
206163
CY2021 nhwk Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
1318359
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-58656
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1060915
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-443968
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-24526231
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5844000
CY2022 nhwk Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
12158238
CY2022 nhwk Increase Decrease In Other Assets Miscellaneous Noncurrent
IncreaseDecreaseInOtherAssetsMiscellaneousNoncurrent
-12233529
CY2021 nhwk Increase Decrease In Other Assets Miscellaneous Noncurrent
IncreaseDecreaseInOtherAssetsMiscellaneousNoncurrent
12193540
CY2022 nhwk Increase Decrease In Deposits Operating Activity
IncreaseDecreaseInDepositsOperatingActivity
-64560
CY2021 nhwk Increase Decrease In Deposits Operating Activity
IncreaseDecreaseInDepositsOperatingActivity
-83122
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3299326
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-126937
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1583308
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-806217
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3126158
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
929023
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-53530
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
17286
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5700364
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38128906
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2457348
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
66960279
CY2022 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
53243519
CY2021 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
78635257
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20117998
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1904713
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
388103
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-2719899
CY2022 us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
22784571
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10991604
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9770265
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
59692
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26304282
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27261
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
658184
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
231633
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
183010
CY2022 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4735000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4906941
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25490349
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3624
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-9719
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
380675
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2878011
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8053879
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10931890
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8434554
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8053879
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6348346
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
88596
CY2022 nhwk Right Of Use Asset Obtained In Exchange For Operating Lease Liability Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityModifications
-81752
CY2021 nhwk Right Of Use Asset Obtained In Exchange For Operating Lease Liability Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityModifications
37767
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
15477515
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
408677
CY2022 nhwk Right Of Use Asset Obtained In Exchange For Finance Lease Liability Modifications
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityModifications
37654
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
288807
CY2022 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
42853685
nhwk Overstatement Understatement Of Net Income Loss Due To Errors In Recognition Of Deferred Tax Asset Valuation Allowance
OverstatementUnderstatementOfNetIncomeLossDueToErrorsInRecognitionOfDeferredTaxAssetValuationAllowance
-3300000
nhwk Overstatement Understatement Of Net Income Loss Due To Errors In Recognition Of Deferred Tax Asset Valuation Allowance
OverstatementUnderstatementOfNetIncomeLossDueToErrorsInRecognitionOfDeferredTaxAssetValuationAllowance
-3300000
CY2022Q2 nhwk Overstatement Understatement Of Net Income Loss Due To Errors In Recognition Of Deferred Tax Asset Valuation Allowance
OverstatementUnderstatementOfNetIncomeLossDueToErrorsInRecognitionOfDeferredTaxAssetValuationAllowance
-3300000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-209200000
CY2022 us-gaap Profit Loss
ProfitLoss
-43900000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
44300000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, useful lives of fixed assets, contingent consideration, valuation of goodwill and other intangible assets, income taxes, valuation of warrant liabilities, stock-based compensation, right-of-use assets and lease liabilities, and useful lives of intangible assets. Actual results may differ from those estimates.</p>
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">Certain prior year amounts have been reclassified to conform to the current year presentation in the consolidated financial statements and accompanying notes to the consolidated financial statements including the IPR&amp;D impairment, which was previously included in research and development expense and is now presented as a separate line item on the Company's consolidated statements of operations and comprehensive loss.</span></p>
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At times, cash balances may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurable limits. The Company has never experienced any losses related to these balances. As of December 31, 2022, and 2021, cash amounts in excess of $250,000 were not fully insured. The uninsured cash balance as of December 31, 2022 was $7.8 million. The Company does not believe it is exposed to significant credit risk on cash and cash equivalents.</p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
7800000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1600000
CY2022 nhwk Amount Of Allowable Expenses Incurred Under Grant
AmountOfAllowableExpensesIncurredUnderGrant
40000.00
CY2021 nhwk Amount Of Allowable Expenses Incurred Under Grant
AmountOfAllowableExpensesIncurredUnderGrant
30000.00
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1700000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
800000
CY2021Q4 nhwk Assets Transfer From Level1 To Level2 Transfers Amount1
AssetsTransferFromLevel1ToLevel2TransfersAmount1
0
CY2022Q4 nhwk Assets Transfer From Level1 To Level2 Transfers Amount1
AssetsTransferFromLevel1ToLevel2TransfersAmount1
0
CY2021 nhwk Income Tax Reconciliation Nondeductible Expense Research And Development Expense
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentExpense
-836000
CY2022 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3452015
CY2021 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
430000
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
29972502
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
55511592
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-33433608
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-10084749
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-1.31
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.40
CY2022Q4 nhwk Prepaid Manufacturing Expense
PrepaidManufacturingExpense
1849875
CY2021Q4 nhwk Prepaid Manufacturing Expense
PrepaidManufacturingExpense
563280
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1432242
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
460030
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
227532
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
704650
CY2022Q4 nhwk Prepaid Preclinical And Clinical Expenses
PrepaidPreclinicalAndClinicalExpenses
65892
CY2021Q4 nhwk Prepaid Preclinical And Clinical Expenses
PrepaidPreclinicalAndClinicalExpenses
1158560
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3575541
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2886520
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23442363
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3662215
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2961988
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1503736
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20480375
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2158479
CY2022 us-gaap Depreciation
Depreciation
1800000
CY2021 us-gaap Depreciation
Depreciation
400000
CY2020Q4 us-gaap Goodwill
Goodwill
1452338
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1452338
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
5067748
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1765789
CY2022Q4 us-gaap Goodwill
Goodwill
3301959
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1176963
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
459178
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1092560
CY2022Q4 nhwk Accrued Clinical Trial Expense Current
AccruedClinicalTrialExpenseCurrent
959992
CY2021Q4 nhwk Accrued Clinical Trial Expense Current
AccruedClinicalTrialExpenseCurrent
955013
CY2022Q4 nhwk Accrued Manufacturing Expenses
AccruedManufacturingExpenses
594358
CY2021Q4 nhwk Accrued Manufacturing Expenses
AccruedManufacturingExpenses
179173
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
438049
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
631312
CY2022Q4 nhwk Accrued Franchise Tax
AccruedFranchiseTax
40000
CY2021Q4 nhwk Accrued Franchise Tax
AccruedFranchiseTax
195000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4301922
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2419676
CY2022Q4 nhwk Future Minimum Royalty Payments Due In Two Years
FutureMinimumRoyaltyPaymentsDueInTwoYears
74000000
CY2022Q4 nhwk Future Minimum Royalty Payments Due In Three Years
FutureMinimumRoyaltyPaymentsDueInThreeYears
775000000
CY2022Q4 nhwk Future Minimum Royalty Payments Due In Four Years
FutureMinimumRoyaltyPaymentsDueInFourYears
25000000
CY2022Q4 nhwk Future Minimum Royalty Payments Due In Five Years
FutureMinimumRoyaltyPaymentsDueInFiveYears
50000000
CY2022Q4 nhwk Future Minimum Royalty Payments Due
FutureMinimumRoyaltyPaymentsDue
924000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25661488
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25649824
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4085737
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
6168981
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4085737
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
6168981
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.87
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.67
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1480139
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.05
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
403743
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1674153
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.65
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70967
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.53
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
49532
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
14.26
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
79478
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2954315
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.62
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100419
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4307599
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.10
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12765
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.30
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
82253
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.20
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
130022
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.44
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7036874
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.67
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16842
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1680455
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.63
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16841
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y6M
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5400000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
192000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3288937
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-145974
CY2022 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
-3288937
CY2021 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
-145974
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9902000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7465000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-198000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
556000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-19000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-16000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1000
CY2022 nhwk Income Tax Reconciliation Nondeductible Expense Research And Development Expense
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentExpense
-1312000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
164000
CY2022 nhwk Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationAmount
9000
CY2021 nhwk Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationAmount
259000
CY2022 nhwk Effective Income Tax Rate Reconciliation Nondeductible Expense Business Acquisition Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBusinessAcquisitionAmount
-41000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
305000
CY2022 nhwk Income Tax Reconciliation Reserve For Loss Carryforwards Limited By Section382
IncomeTaxReconciliationReserveForLossCarryforwardsLimitedBySection382
8000
CY2021 nhwk Income Tax Reconciliation Reserve For Loss Carryforwards Limited By Section382
IncomeTaxReconciliationReserveForLossCarryforwardsLimitedBySection382
8000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-99937
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-32974
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8073000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6911000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3288937
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-145974
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23938503
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17830889
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
4132625
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2538168
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2974242
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2344902
CY2021Q4 nhwk Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
767763
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
7465
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
8039
CY2022Q4 nhwk Deferred Tax Assets Amortization Of Research And Experimental Expenditures
DeferredTaxAssetsAmortizationOfResearchAndExperimentalExpenditures
4690801
CY2022Q4 nhwk Deferred Tax Assets Unrealized Gains Losses
DeferredTaxAssetsUnrealizedGainsLosses
584079
CY2021Q4 nhwk Deferred Tax Assets Unrealized Gains Losses
DeferredTaxAssetsUnrealizedGainsLosses
210300
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
36327715
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23700061
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1991789
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
803937
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
553332
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
83122
CY2022Q4 nhwk Deferred Tax Liabilities Lease Liability
DeferredTaxLiabilitiesLeaseLiability
2743364
CY2021Q4 nhwk Deferred Tax Liabilities Lease Liability
DeferredTaxLiabilitiesLeaseLiability
78035
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
99272
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
83931
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5387757
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1049025
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30939958
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22866973
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
215937
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30939958
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 nhwk Number Of Ownership Changes Over Fifty Percent
NumberOfOwnershipChangesOverFiftyPercent
5
CY2022Q4 nhwk Lease Liability To Be Paid Year Four
LeaseLiabilityToBePaidYearFour
1170658
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
592572
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
615269
CY2022Q4 nhwk Lease Liability To Be Paid Year Five
LeaseLiabilityToBePaidYearFive
1207841
CY2022Q4 nhwk Lessee Operating Lease Liability To Be Paid Year Six
LesseeOperatingLeaseLiabilityToBePaidYearSix
610407
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2022 nhwk Leases Effective Interest Rate Percent
LeasesEffectiveInterestRatePercent
0.0580
CY2021 nhwk Leases Effective Interest Rate Percent
LeasesEffectiveInterestRatePercent
0.0530
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
870939
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
474135
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
656794
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
185171
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
181667
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21970
CY2022 us-gaap Lease Cost
LeaseCost
838461
CY2021 us-gaap Lease Cost
LeaseCost
207141
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P13Y3M18D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0930
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0632
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0960
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0530
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
791502
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
769621
CY2022Q4 nhwk Lease Liability To Be Paid Year One
LeaseLiabilityToBePaidYearOne
1561123
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
618918
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
812383
CY2022Q4 nhwk Lease Liability To Be Paid Year Two
LeaseLiabilityToBePaidYearTwo
1431301
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
635180
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
715782
CY2022Q4 nhwk Lease Liability To Be Paid Year Three
LeaseLiabilityToBePaidYearThree
1350962
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
575349
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
595309
CY2022Q4 nhwk Finance Lease Liability To Be Paid Year Six
FinanceLeaseLiabilityToBePaidYearSix
635827
CY2022Q4 nhwk Lease Liability To Be Paid Year Six
LeaseLiabilityToBePaidYearSix
1246234
CY2022Q4 nhwk Lessee Operating Lease Liability To Be Paid After Year Six
LesseeOperatingLeaseLiabilityToBePaidAfterYearSix
1166271
CY2022Q4 nhwk Finance Lease Liability To Be Paid After Year Six
FinanceLeaseLiabilityToBePaidAfterYearSix
7080308
CY2022Q4 nhwk Lease Liability To Be Paid After Year Six
LeaseLiabilityToBePaidAfterYearSix
8246579
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4990199
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
11224499
CY2022Q4 nhwk Lease Liability Payment Due
LeaseLiabilityPaymentDue
16214698
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1419934
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
5403417
CY2022Q4 nhwk Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
6823351
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3570265
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5821082
CY2022Q4 nhwk Lease Liability
LeaseLiability
9391347
CY2022 nhwk Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.012
CY2022 us-gaap Profit Loss
ProfitLoss
-43862197
CY2021 us-gaap Profit Loss
ProfitLoss
-35400807
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-427491
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-329339
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-43434706
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-35071468
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25606326
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25606326
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24913942
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24913942
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.70
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.70
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.41
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
215937
CY2022Q2 us-gaap Liabilities
Liabilities
33141130
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
180670826
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
99964241
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98713663
CY2022Q3 us-gaap Goodwill
Goodwill
3214747
CY2022Q3 us-gaap Assets
Assets
119911913
CY2022Q3 us-gaap Liabilities
Liabilities
33713188
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
193929176
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
87538725
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
86198726
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3326000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3326000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-6937910
us-gaap Profit Loss
ProfitLoss
-15127708
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6831286
us-gaap Net Income Loss
NetIncomeLoss
-14951873
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6788055
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-15033122
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6681431
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14857287
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37063
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3288937
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13347771
us-gaap Profit Loss
ProfitLoss
-28475479
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13258350
us-gaap Net Income Loss
NetIncomeLoss
-28210223
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.10
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-13232112
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28265234
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13142691
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27999978
us-gaap Profit Loss
ProfitLoss
-15127708
us-gaap Profit Loss
ProfitLoss
-28475479
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-3326000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-3288937

Files In Submission

Name View Source Status
nhwk-20221231_cal.xml Edgar Link unprocessable
0001558370-23-005289-index-headers.html Edgar Link pending
0001558370-23-005289-index.html Edgar Link pending
0001558370-23-005289.txt Edgar Link pending
0001558370-23-005289-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nhwk-20221231.xsd Edgar Link pending
nhwk-20221231x10k.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nhwk-20221231x10k_htm.xml Edgar Link completed
nhwk-20221231xex10d62.htm Edgar Link pending
nhwk-20221231xex10d63.htm Edgar Link pending
nhwk-20221231xex21d1.htm Edgar Link pending
nhwk-20221231xex23d1.htm Edgar Link pending
nhwk-20221231xex31d1.htm Edgar Link pending
nhwk-20221231xex31d2.htm Edgar Link pending
nhwk-20221231xex32d1.htm Edgar Link pending
nhwk-20221231xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
nhwk-20221231_def.xml Edgar Link unprocessable
nhwk-20221231_lab.xml Edgar Link unprocessable
nhwk-20221231_pre.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending